Published in ScientificWorldJournal on December 10, 2012
Atherosclerosis and the role of immune cells. World J Clin Cases (2015) 0.83
Associations between variants in IL-33/ST2 signaling pathway genes and coronary heart disease risk. Int J Mol Sci (2014) 0.77
The role of the intraplaque vitamin d system in atherogenesis. Scientifica (Cairo) (2013) 0.76
Dexamethasone Suppresses Oxysterol-Induced Differentiation of Monocytic Cells. Oxid Med Cell Longev (2016) 0.75
Diclofenac Inhibits 27-hydroxycholesterol-induced Differentiation of Monocytic Cells into Mature Dendritic Cells. Immune Netw (2017) 0.75
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med (2007) 5.28
Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev (2006) 5.27
A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol (2009) 5.26
Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28
Innate and acquired immunity in atherogenesis. Nat Med (2002) 4.22
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest (1997) 4.18
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1995) 3.54
Protective role of interleukin-10 in atherosclerosis. Circ Res (1999) 3.28
Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation (2000) 3.17
Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res (2008) 3.16
Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res (2001) 3.07
Inflammation in atherosclerosis: transition from theory to practice. Circ J (2010) 2.98
Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J (2006) 2.93
Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation (2009) 2.77
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation (2003) 2.70
Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation (2010) 2.69
Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol (2004) 2.59
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation (2006) 2.55
The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol (2008) 2.48
Dendritic cell subsets in health and disease. Immunol Rev (2007) 2.45
Role of monocytes in atherogenesis. Physiol Rev (2003) 2.30
C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost (2006) 2.25
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol (2003) 2.20
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med (2009) 2.17
T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A (1997) 2.03
Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation (2005) 2.03
Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol (2009) 2.03
Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.98
Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med (2003) 1.95
Heat shock proteins, inflammation, and cardiovascular disease. Circulation (2002) 1.87
Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost (2011) 1.85
Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation (2002) 1.80
Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol (2000) 1.80
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.79
Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.79
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest (1998) 1.76
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation (2002) 1.72
Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation (2012) 1.71
Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res (2007) 1.70
Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol (2010) 1.70
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest (1997) 1.67
Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation (2003) 1.67
Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis (2004) 1.64
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation (2008) 1.64
Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation (2003) 1.59
Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler Thromb Vasc Biol (2002) 1.58
IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect (2009) 1.58
Lymphocytes are important in early atherosclerosis. J Clin Invest (2001) 1.57
T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation (2001) 1.57
A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol (2010) 1.51
Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb (1992) 1.46
Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) (2007) 1.43
Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation (2006) 1.41
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther (2005) 1.38
T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A (2003) 1.37
IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol (2010) 1.36
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun (2009) 1.36
Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation (2001) 1.31
The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol (2007) 1.22
Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation (2003) 1.16
Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med (2008) 1.12
Intraplaque hemorrhage. Curr Mol Med (2006) 1.12
Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol (2009) 1.12
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost (2011) 1.10
Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.09
Evidence for antigen-driven T-cell response in unstable angina. Circulation (2000) 1.09
Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells. Eur J Immunol (2011) 1.09
Chemokines: inflammatory mediators of atherosclerosis. Arch Physiol Biochem (2006) 1.08
Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E. Arterioscler Thromb Vasc Biol (1998) 1.07
Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis (2012) 1.06
Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol (2004) 1.06
Interleukin-17: friend or foe in atherosclerosis? Curr Opin Lipidol (2010) 1.06
Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res (Hoboken) (2011) 1.05
Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.05
Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nat Clin Pract Cardiovasc Med (2008) 1.05
Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol (2005) 1.05
Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood (2005) 1.04
Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med (2007) 1.04
Heat shock proteins in vascular disease--a review. Eur J Vasc Endovasc Surg (2005) 1.03
Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol (2005) 1.02
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A (2012) 0.99
Advanced glycation end products of human β₂ glycoprotein I modulate the maturation and function of DCs. Blood (2011) 0.99
Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97
TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol (2006) 0.96
Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis (2005) 0.95
Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication. Atherosclerosis (2011) 0.93
Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis. Trends Cardiovasc Med (2009) 0.92
An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Vasc Med (2007) 0.92
Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis (2009) 0.91
Intracellular expression of cytokines in peripheral blood from patients with atherosclerosis before and after carotid endarterectomy. Atherosclerosis (2006) 0.90
Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol (2009) 0.90
Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res (2004) 0.87
Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost (2012) 0.85
Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses. Int J Inflam (2011) 0.85
Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infect Immun (2007) 1.37
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum (2007) 1.18
In vitro analysis of iron chelating activity of flavonoids. J Inorg Biochem (2011) 1.16
An update on immunodiagnosis of cystic echinococcosis. Acta Trop (2003) 1.06
Molecular cross-talk in host-parasite relationships: the intriguing immunomodulatory role of Echinococcus antigen B in cystic echinococcosis. Int J Parasitol (2008) 1.06
Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood (2005) 1.04
Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry. Biochim Biophys Acta (2004) 1.03
Immunomodulatory mechanisms during Echinococcus granulosus infection. Exp Parasitol (2008) 1.00
Advanced glycation end products of human β₂ glycoprotein I modulate the maturation and function of DCs. Blood (2011) 0.99
Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems. Biochimie (2010) 0.98
Cellular and molecular players in the atherosclerotic plaque progression. Ann N Y Acad Sci (2012) 0.95
Pleiotropic effects of statins in atherosclerotic disease: focus on the antioxidant activity of atorvastatin. Curr Top Med Chem (2014) 0.94
Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease. Arthritis Res Ther (2006) 0.91
Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis (2009) 0.91
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther (2005) 0.90
In vitro interactions of coumarins with iron. Biochimie (2010) 0.90
Intracellular expression of cytokines in peripheral blood from patients with atherosclerosis before and after carotid endarterectomy. Atherosclerosis (2006) 0.90
Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. Neuropharmacology (2011) 0.89
Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress. Biochimie (2011) 0.89
Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann N Y Acad Sci (2007) 0.89
4-methylcoumarins as antioxidants: scavenging of peroxyl radicals and inhibition of human low-density lipoprotein oxidation. Biochimie (2010) 0.87
Activation and inhibition of Candida rugosa and Bacillus-related lipases by saturated fatty acids, evaluated by a new colorimetric microassay. Biochim Biophys Acta (2004) 0.87
Mechanism of thermal aggregation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Biochemistry (2006) 0.87
Antioxidant activity of 4-methylcoumarins. J Pharm Pharmacol (2007) 0.85
Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses. Int J Inflam (2011) 0.85
Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders. Mediators Inflamm (2012) 0.85
Interaction of polyelectrolytes with proteins, 3. Influence of complexing polycations on the thermoaggregation of oligomeric enzymes. Macromol Biosci (2007) 0.83
Development of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography. Biomed Chromatogr (2002) 0.83
Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Horm Behav (2009) 0.83
Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol (2006) 0.83
Dietary phenolic acids and derivatives. Evaluation of the antioxidant activity of sinapic acid and its alkyl esters. J Agric Food Chem (2010) 0.83
Interaction of polyanions with basic proteins, 2(a) : influence of complexing polyanions on the thermo-aggregation of oligomeric enzymes. Macromol Biosci (2005) 0.82
Protein acyltransferase function of purified calreticulin: the exclusive role of P-domain in mediating protein acylation utilizing acyloxycoumarins and acetyl CoA as the acyl group donors. Protein Pept Lett (2011) 0.82
Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation: novel therapeutic targets for atherosclerosis. Curr Med Chem (2013) 0.82
Free hemoglobin: a dangerous signal for the immune system in patients with carotid atherosclerosis? Ann N Y Acad Sci (2007) 0.82
Thioredoxin peroxidase from Echinococcus granulosus: a candidate to extend the antigenic panel for the immunodiagnosis of human cystic echinococcosis. Diagn Microbiol Infect Dis (2007) 0.82
Resveratrol prevents dendritic cell maturation in response to advanced glycation end products. Oxid Med Cell Longev (2013) 0.82
Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect Immun (2004) 0.82
Pharmacological applications of antioxidants: lights and shadows. Curr Drug Targets (2014) 0.82
Iron reduction potentiates hydroxyl radical formation only in flavonols. Food Chem (2012) 0.82
Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies. J Pharm Pharmacol (2009) 0.81
Helicobacter pylori EstV: identification, cloning, and characterization of the first lipase isolated from an epsilon-proteobacterium. Appl Environ Microbiol (2007) 0.81
Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines. Arch Pharm Res (2013) 0.81
The mechanism of antioxidant activity of IRFI005 as a synthetic hydrophilic analogue of vitamin E. Biochimie (2011) 0.81
Oxidized haemoglobin as antigenic target of cell-mediated immune reactions in patients with carotid atherosclerosis. Autoimmun Rev (2009) 0.81
Effect of alpha-crystallin on thermal denaturation and aggregation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Biophys Chem (2006) 0.81
Redox imbalance of red blood cells impacts T lymphocyte homeostasis: implication in carotid atherosclerosis. Thromb Haemost (2011) 0.81
The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates. Biol Pharm Bull (2009) 0.81
Short- and long-term regulation of 3-hydroxy 3-methylglutaryl coenzyme A reductase by a 4-methylcoumarin. Biochimie (2011) 0.80
Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders. Curr Top Med Chem (2015) 0.80
7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages. Biochem Pharmacol (2013) 0.80
Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease. Biochim Biophys Acta (2007) 0.80
Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.80
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Arterioscler Thromb Vasc Biol (2014) 0.79
Haemoglobin triggers chemotaxis of human monocyte-derived dendritic cells: possible role in atherosclerotic lesion instability. Atherosclerosis (2011) 0.79
Regression of oxidative stress by targeting eNOS and Nrf2/ARE signaling: a guided drug target for cardiovascular diseases. Curr Top Med Chem (2015) 0.79
Antimicrobial and anti-lipase activity of quercetin and its C2-C16 3-O-acyl-esters. Bioorg Med Chem (2002) 0.79
Identification of a carboxylesterase-producing Rhodococcus soil isolate. Can J Microbiol (2005) 0.79
Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures. Biochim Biophys Acta (2008) 0.79
Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction. J Mol Cell Cardiol (2012) 0.78
Surgical treatment of spontaneous common carotid dissection: a case report. Ann Ital Chir (2014) 0.78
Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM. Biochimie (2011) 0.78
Structure-activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: correlation between experimental & theoretical data and synergistic effect. Biochimie (2010) 0.78